Vuno Inc. (South Korea)

The company is a Korea-based company primarily engaged in the development of medical diagnostic, predictive technologies and solutions based on artificial intelligence (AI) technology. The Company develops and manufactures medical imaging products that assist with medical image-based diagnosis such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and funduscopy; pathology products that assist in the detection of digital scanners, microscopy-based cell quantification and tumor cells; biosignal products that assist and predict diagnosis based on time-series biosignal data such as vital signs and electrocardiogram; medical voice products that automatically create medical charts based on voice recognition. In addition, the Company sells an embolic material product, Nexpear. The Company was established on December 10, 2014. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 26, 2021.